Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs) including recommendations regarding contamination of herbal medicinal products with pyrrolizidine alkaloids. EMA/HMPC/893108/2011 Rev. 1 - European Medicines Agency (EMA)
Accessed June 1, 2021 at: